Article Information
History
- February 9, 2021.
Article Versions
- Version 1 (January 26, 2021 - 05:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Camille Lassale, PhD1,2,3,*,
- Mark Hamer, PhD4,
- Álvaro Hernáez, PharmD, PhD5,2,6,
- Catharine R. Gale, PhD7,8 and
- G. David Batty, PhD, DSc9
- 1Hospital del Mar Medical Research Institute, Barcelona, Spain
- 2Instituto de Salud Carlos III, Madrid, Spain
- 3Department of Epidemiology and Public Health, University College London, UK
- 4Division of Surgery and Interventional Sciences, University College London, London, UK
- 5Hospital del Mar Medical Research Institute, Barcelona, Spain
- 6August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain
- 7MRC Lifecourse Epidemiology Unit, University of Southampton, UK
- 8Lothian Birth Cohorts, Department of Psychology, University of Edinburgh, UK
- 9Department of Epidemiology and Public Health, University College London, London
- ↵* Corresponding author; email: classale{at}imim.es
Author contributions: GDB, MH and CL generated the idea for the present analyses; CRG prepared the data set; CL analysed the data; and CL and GDB prepared a draft of the manuscript on which all authors commented.
Posted February 09, 2021.
Association of pre-pandemic high-density lipoprotein cholesterol with risk of COVID-19 hospitalisation and death: the UK Biobank cohort study
